rs144251231
Variant names:
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2
The NM_005199.5(CHRNG):c.1035+25A>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00152 in 1,397,422 control chromosomes in the GnomAD database, including 28 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.0077 ( 13 hom., cov: 32)
Exomes 𝑓: 0.00076 ( 15 hom. )
Consequence
CHRNG
NM_005199.5 intron
NM_005199.5 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: -2.71
Publications
0 publications found
Genes affected
CHRNG (HGNC:1967): (cholinergic receptor nicotinic gamma subunit) The mammalian muscle-type acetylcholine receptor is a transmembrane pentameric glycoprotein with two alpha subunits, one beta, one delta, and one epsilon (in adult skeletal muscle) or gamma (in fetal and denervated muscle) subunit. This gene, which encodes the gamma subunit, is expressed prior to the thirty-third week of gestation in humans. The gamma subunit of the acetylcholine receptor plays a role in neuromuscular organogenesis and ligand binding and disruption of gamma subunit expression prevents the correct localization of the receptor in cell membranes. Mutations in this gene cause Escobar syndrome and a lethal form of multiple pterygium syndrome. Muscle-type acetylcholine receptor is the major antigen in the autoimmune disease myasthenia gravis.[provided by RefSeq, Sep 2009]
TIGD1 (HGNC:14523): (tigger transposable element derived 1) The protein encoded by this gene belongs to the tigger subfamily of the pogo superfamily of DNA-mediated transposons in humans. These proteins are related to DNA transposons found in fungi and nematodes, and more distantly to the Tc1 and mariner transposases. They are also very similar to the major mammalian centromere protein B. The exact function of this gene is not known. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.89).
BP6
Variant 2-232543724-A-C is Benign according to our data. Variant chr2-232543724-A-C is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 259663.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.00772 (1174/152006) while in subpopulation AFR AF = 0.0269 (1113/41428). AF 95% confidence interval is 0.0256. There are 13 homozygotes in GnomAd4. There are 569 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 13 AR gene
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| CHRNG | ENST00000651502.1 | c.1035+25A>C | intron_variant | Intron 9 of 11 | NM_005199.5 | ENSP00000498757.1 | ||||
| CHRNG | ENST00000389492.3 | c.879+25A>C | intron_variant | Intron 8 of 10 | 1 | ENSP00000374143.3 | ||||
| TIGD1 | ENST00000408957.7 | c.*4383T>G | downstream_gene_variant | 6 | NM_145702.4 | ENSP00000386186.3 |
Frequencies
GnomAD3 genomes AF: 0.00773 AC: 1174AN: 151890Hom.: 13 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
1174
AN:
151890
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.00193 AC: 477AN: 247674 AF XY: 0.00158 show subpopulations
GnomAD2 exomes
AF:
AC:
477
AN:
247674
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000761 AC: 948AN: 1245416Hom.: 15 Cov.: 18 AF XY: 0.000684 AC XY: 431AN XY: 630136 show subpopulations
GnomAD4 exome
AF:
AC:
948
AN:
1245416
Hom.:
Cov.:
18
AF XY:
AC XY:
431
AN XY:
630136
show subpopulations
African (AFR)
AF:
AC:
778
AN:
29360
American (AMR)
AF:
AC:
61
AN:
44326
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
24844
East Asian (EAS)
AF:
AC:
0
AN:
38644
South Asian (SAS)
AF:
AC:
6
AN:
81904
European-Finnish (FIN)
AF:
AC:
0
AN:
52050
Middle Eastern (MID)
AF:
AC:
9
AN:
5366
European-Non Finnish (NFE)
AF:
AC:
10
AN:
915584
Other (OTH)
AF:
AC:
84
AN:
53338
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.491
Heterozygous variant carriers
0
53
105
158
210
263
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
24
48
72
96
120
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.00772 AC: 1174AN: 152006Hom.: 13 Cov.: 32 AF XY: 0.00766 AC XY: 569AN XY: 74300 show subpopulations
GnomAD4 genome
AF:
AC:
1174
AN:
152006
Hom.:
Cov.:
32
AF XY:
AC XY:
569
AN XY:
74300
show subpopulations
African (AFR)
AF:
AC:
1113
AN:
41428
American (AMR)
AF:
AC:
49
AN:
15282
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
3468
East Asian (EAS)
AF:
AC:
0
AN:
5154
South Asian (SAS)
AF:
AC:
0
AN:
4810
European-Finnish (FIN)
AF:
AC:
0
AN:
10580
Middle Eastern (MID)
AF:
AC:
0
AN:
292
European-Non Finnish (NFE)
AF:
AC:
2
AN:
67972
Other (OTH)
AF:
AC:
10
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.506
Heterozygous variant carriers
0
55
110
165
220
275
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
6
AN:
3478
ClinVar
Significance: Benign/Likely benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Nov 20, 2020
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.